Plasma concentrations of luteinizing hormone (LH), follicle stimulating hormone (FSH) and prolactin (PRL) were determined over a 24-h period using radioimmunoassay in sheep injected with corn oil (control) or various doses of zeranol or estradiol-173. Injection of .333, 1 or 10 mg of zeranol caused dose-related increases (P<.01) in plasma PRL (peak levels at 12 to 18 h) and LH (peak levels at 12 to 20 h) in ovariectomized ewes. Similarly, PRL and LH increased following doses of 33 or 100 /~g of estradiol. Before the LH surge, plasma LH levels were significantly depressed (4 to 8 h). Plasma FSH levels were significantly decreased 4 to 8 h after zeranol and estradiol injection. Slight surges of FSH were observed at times similar to those of LH, but the peak level was never greater than control levels. Injection of 1 mg of zeranol or 100 /lg of estradiol into wethers resulted in a 24-h pattern of PRL secretion not significantly different from the controls, a transient depression of Ltt concentration and significantly prolonged inhibition of FSH secretion. These results indicate similarities in the effects of zeranol and estradiol on anterior pituitary hormone secretion within groups of animals of the same sex or reproductive state. Differences in secretion and plasma concentrations of LH, FSH and PRL due to underlying sexual dimorphism are maintained and expressed even when animals are challenged with structurally different compounds of varying estrogenic potencies.
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I ntroduction
Secretion of hormones from the anterior pituitary gland is modulated by estrogenic steroid hormones (Bogdanove et al., 1975; Yen et al., 1975; MacLeod, 1976; Pelletier, 1976; Everett, 1977) . Zeranol, a nonsteroidal growth promotant (Stob et al., 1962; Perry et al., 1970) , may alter pituitary hormone secretion through an estrogen-like action on the pituitary (Peck and Chesworth, 1977) . It is known that supplementation or removal of sex steroids results in a resetting of the hypothalamicpituitary axis such that the secretory patterns of gonadotropins and prolactin are altered. The use of zeranol as an injection or implant presents an intriguing variation in the form of an estrogenic supplement, particularly in orchidectomized animals. Pituitary hormone responses of male and female animals to zeranol could be significantly influenced by sexual dimorphic development (Van Dieten et al., 1974; Pelletier, 1976) .
Thorough knowledge of the influences of zeranol on anterior pituitary hormone secretion is essential in light of the need for information on minimal effective doses and their ultimate impact on tissue residues of zeranol and understanding the hormonal activity of zeranol itself.
Characterization of the effects of zeranol on pituitary hormone secretion in sheep was undertaken, and involved the determination of acute, chronic and releasing factor-stimulated hormone secretion patterns. The present study was designed to characterize and compare the short term (24 h) effects of single im injections of zeranol and estradiol-173 on plasma concentrations of luteinizing hormone (LH), follicle stimulating hormone (FStt) and prolactin (PRL) in wethers and ovariectomized ewes.
These data form a base with which to compare the effects of more prolonged administration of zeranol on hormone secretion. The influence of zeranol on hormone secretion and tissue response may be an important factor in some of the side effects observed during the zeranol implant period in domestic animals that can result in poor weight gain (Rothenbacher et al., 1975) .
Materials end Methods
Ovariectomized ewes (1 yr postovariectomy, 40 to 45 kg) and wethers (2 mo postcastration, 22 to 28 kg) were used in these studies. Ewes and wethers were randomly assigned to treatment groups and maintained in floor pens with constant lighting during the 24-h experimental period. Water was provided ad libitum. Feed was withdrawn from wethers 6 h before initial blood sampling. Ewes had access to pelleted alfalfa throughout the sampling period. Studies were conducted between mid-January and mid-March.
To determine the effect of dose of zeranol or estradiol on' pituitary hormone secretion in ewes, various amounts of zeranol 4 (.033, .1, .333, 1 or 10 mg) or estradiol-17• (3.3, 33 or 100 #g) were administered. Four ewes were allotted per level of zeranol or estradiol-173. Twenty-four wethers were equally divided and assigned to either zeranol (1 mg), estradiol (100 /ag) or control treatment groups. Zeranol, estradiol-173 or corn oil vehicle was administered via two .5-ml injections, one into each hind leg.
To facilitate repetitive blood sampling, a polyethylene cannula fitted with a three-way stopcock was inserted into the right jugular vein 2 h before the start of blood sampling. Blood samples (7 ml) were drawn from each animal via syringe, and the blood was added to heparinized tubes (143 U heparin/tube) and chilled. After an initial pretreatment blood sample was taken (1800 h), zeranol, estradiol or corn oil was injected im. Additional blood samples were taken at 4, 8, 10, 12, 14, 16, 18, 20 and 24 h postinjection. Blood was centrifuged and the plasma was frozen until plasma concentrations of LH, FSH and PRL were measured using double-antibody radioimmunoassays (Echternkamp et al., 1976; Bolt, 1981 (NIH-S-10) were radioiodinated for use as assay tracers. Iodination of hormones for tracers was performed with chloramine-T (Bolt, 1981) . Plasma hormone concentrations are given as ng/ml, relative to NIH-LH-S12, NIH-FSH-S10 and NIH-PRL-S10 reference standards.
Hormone secretion patterns over a 24-h period were analyzed by analysis of variance fi~r a split-plot design for the effects due to: animals within treatment, treatment, time and treatment x time (Snedecor and Cochran, 1967) using the general linear model procedure of Statistical Analysis Systems (SAS, 1979) . To correct for heterogeneity of variance, ali data were transformed to logarithms before statistical analysis. The shapes of the secretory profile curves of ewes were subjected to further analysis to best fit the data to a polynomial function (Snedecor and Cochran, 1967) . Unless otherwise indicated, the significance of a result will be achieved when P is <.05. 
Results
Changes during a 24-h period in plasma concentrations of LH, FSH and PRL in ovariectomized ewes treated with various doses of zeranol are illustrated in figure 1. Zeranol doses of .033 and .1 mg did not affect (P>.05) hormone secretion and, for clarity, are omitted from the figures. Luteinizing hormone responses to zeranol (top frame, figure 1) were biphasic. There was an initial 4-to 8-h period when plasma LH concentrations were lower than control levels. This was followed by a dosedependent hormone surge, which began at approximately 10 h and peaked at 12 to 16 h after the injection Of zeranol. The initial decline and following surge of LH was significant with doses of .333, 1 and 10 mg of zeranol. Consistent with the biphasic pattern of release, 24-h LH secretion curves for zeranol were best described by a cubic mathematical model. Control LH secretion during this period was linear (P<.05) with an overall slope of 0. In ewes, FSH was measured only in animals that received doses of 0, I and 10 mg of zeranol. Plasma concentrations of FSH (middle frame, figure 1) were reduced (P<.05) at 4 to 8 h postadministration of zeranol (1 and 10 mg). The concentration of FSH slowly returned to pretreatment control concentrations by 12 to 14 h after injection. The shapes of the zeranol curves for FSH secretion were fitted to a quadratic expression, differing from the linear control or cubic LH curves.
Zeranol stimulated PRL secretion in ewes. Peak levels of PRL were dose-dependent and occurred between 12 and 18 h after dosing (bottom frame, figure 1). The shape of the 24-h PRL secretion curve after zeranol was tested and found to fit a quadratic function.
Changes in plasma hormone concentrations of LH, FSH and PRL following administration of estradiol-17~ are reflected in the secretion curves illustrated in figure 2. For the three hormones measured, the data indicated plasma hormone profiles significantly different (P<.01) from control values during the 20-h period and similar to those observed in animals that received effective doses of zeranol. Luteinizing hormone secretion was biphasic. Estradiol doses of 33 and 100 /~g initially reduced plasma LH (P<.05), while a subsequent surge of LH was obtained with doses of 3.3, 33 and 100/~g. The secretion profile curves were best fitted to cubic expressions. Doses of estradiol-17/3 greater than 3.3 /lg caused a reduction in systemic FSH (P<.05; middle frame, figure 2 ) and all estradiol doses caused a significant increase in plasma PRL (P<.05; bottom frame, figure 2 ). Both FSH and PRL secretion curves were best fit to respective quadratic functions.
The treatment • time interaction was used to test differences from the controls in the shapes of the 24-h hormone secretion curves resulting from zeranol and estradiol treatment. A summary of the probability of significance of the F-value generated in the treatment x time interaction in the analysis of variance for data of ewes is presented in table 1. In general, both zeranol and estradiol caused significant doserelated deviations from control secretory patterns of LH, FSH and PRL. Administration of 1 mg of zeranol or 100 /lg of estradiol produced no difference in the secretion of LH and PRL. A slight difference in secretion of FSH under the influence of these compounds was evident.
Illustrated in figure 3 are the 24-h plasma hormone profiles for wethers after treatment with either corn oil, zeranol or estradiol. Inhibition of LH and FSH secretion, as indicated by reduced plasma concentration of hormones, was evident 4 to 8 h postinjection. By 10 to 12 h postinjection, plasma LH had returned to preinjection levels but plasma FSH remained low throughout the 24-h sampling period. In contrast to LH in ewes, estradiol treatment in wethers did not produce an elevation in plasma LH greater than control levels. Treatment with zeranol resulted in a slight elevation (P<.05) in plasma LH compared with control levels. Prolactin levels after zeranol and estradiol administration were not significantly different from control (corn oil) levels during the sampling period. Peak concentrations and total area under the curve for PRL after zeranol and estradiol were less than those measured in ewes to which the same doses of zeranol and estradiol had been administered.
Discussion
Although doses of zeranol required to alter pituitary secretion were greater than those required with estradiol, the resulting profiles for the hormones (LH, FSH and PRL) were similar. Few data are available to directly compare the (Diekman and Malven, 1973; Beck et al., 1976; Hauger et al., 1977) . The long-term effect of implanted zeranol was an overall reduction in systemic levels of gonadotropins (Riesen et al., 1977) . The effects of estradiol on acute pituitary secretion of LH, FSH and PRL are consistent with those reported previously for ewes, heifers and ovariectomized cows (Scaramuzzi et al., 1971; Hobson and Hansel, 1972; Howland and Palmer, 1973; Gonzalez-Padilla et al., 1975; Hausler and Malven, 1976; Jackson and Davis, 1979; Forrest et al., 1981) . The magnitude and timing of plasma hormone concentration changes after estradiol were similar to those reported previously (Scaramuzzi et al., 1971; Bolt, 1981) . Likewise, the effects of estradiol on hormone profiles in ewes were similar to profiles observed in estradiol-treated rams (Bolt, 1971) and wethers (Riggs and Malven, 1974) . Overall, 24-h hormone profiles of LH, FSH and PRL in wethers and ewes indicate reduced sensitivity and responsiveness of the male to estrogen-induced PRL secretion and decreased acute pituitary responsiveness to estrogenic stimulation of gonadotropins and PRL in males relative to females. Generally, sensitivity to acute inhibition of LH and FSH secretion was maintained in both sexes of animals. The general shapes of the secretory profile curves reflect the differences in sensitivity and responsiveness to estrogenic compounds in the hypothalamus and pituitary glands of castrated male and female animals.
Several reports suggest that histological changes in pituitary and other reproductive tissues of zeranol-treated cattle and sheep are a result of an estrogenic effect of zeranol (Rothenbacher et al., 1975; Azzali, 1977; Wiggins et al., 1980) . This effect may involve a direct action of zeranol on the tissue. In a separate study, we compared the potency of zeranol and estradiol in a competitive uterine cytosol receptor assay (Rexroad, 1981) . The potency of zeranol was about 30% that of estradiol (T. H. Elsasser and D. J. Bolt, unpublished observations). Binding of zeranol to estrogen receptors has also been observed by Peck and Chesworth (1977) . Thus, it is possible for zeranol, though nonsteroidal, to interact with estrogen receptors and elicit estrogen-like responses.
The effects of zeranol and estradiol on the secretion patterns of LH, FSH and PRL are similar. Presumably, zeranol and estradiol exert their effects through common mechanisms that involve interaction between zeranol and estradiol and estrogen receptors within the hypothalamus and pituitary. The combination of direct tissue interactions and secondary effects produced through altered LH and FSH secretion was evident in histochemical changes in primary and secondary sex structures of rams and wethers implanted with zeranol or diethylstilbestrol (Rothenbacher et al., 1975; Wiggins et al., 1976) . Data in this study refine, confirm and extend our understanding of the estrogenlike feedback effects of zeranol on the hypothalamo-hypophyseal unit, which controls the secretion of LH, FSH and PRL. Regardless of the chemical nature or potency of the estrogenic compound, the resulting profiles of secretion reflected the presence and expression of the sexual dimorphism underlying pituitary hormone responses to exogenous estrogens in wethers and ovariectomized ewes. The present data are interpreted to suggest that estrogenic anabolic compounds such as zeranol alter normal patterns of pituitary LH, FSH and PRL secretion by mechanisms analogous to those characteristic of estradiol.
